Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Immunex -- Ignore unavailable to you. Want to Upgrade?

To: synchro who wrote (355)	8/6/1999 8:39:00 AM
From: RickM	Read Replies (1) \| Respond to of 656

(ZACKS) ZACKS RESEARCH STORY FOR: Immunex Corp. ZACKS RESEARCH STORY FOR: Immunex Corp. ============== [IMNX] ZACKS RESEARCH STORY FOR: Immunex Corp. =============== (IMNX) Immunex Corp. CUSIP: 452528102 Seattle, WA TEL: 206-389-4363 FYE: 12 ZRANK: 3 ============================================================================== 8/5 Price 52 W Low 52 W High YTD % Chg 10D % Chg 12M P/E FY1 P/E 114.25 24.94 142.31 81.61 0.94 761.7 193.6 ============================================================================== ESTIMATE CHANGES FOR THE FISCAL YEAR ENDING DECEMBER 1999 ----------------------------------------------------------------------------- Aug. 3 -- A Major Broker raised the estimated earnings per share of Immunex Corp. for the fiscal year ending December 1999 to 90 cents from 65 cents. > ZACKS >> The Zacks consensus estimate, for the fiscal year ending December 1999 is 59 cents. The consensus drawn from estimates made over the past 30 days is 57 cents. ESTIMATE CHANGES FOR THE QUARTER ENDING SEPTEMBER 1999 ----------------------------------------------------------------------------- Aug. 3 -- A Major Broker raised the estimated earnings per share of Immunex Corp. for the quarter ending September 1999 to 30 cents from 19 cents. > ZACKS >> The Zacks consensus estimate, for the quarter ending September 1999 is 23 cents. The consensus drawn from estimates made over the past 30 days is 22 cents. ESTIMATE CHANGES FOR THE QUARTER ENDING DECEMBER 1999 ----------------------------------------------------------------------------- Aug. 3 -- A Major Broker raised the estimated earnings per share of Immunex Corp. for the quarter ending December 1999 to 51 cents from 38 cents. > ZACKS >> The Zacks consensus estimate, for the quarter ending December 1999 is 28 cents. The consensus drawn from estimates made over the past 30 days is 27 cents. All estimates and earnings are for continuing operations diluted EPS. The information in this report has been taken from trade and statistical sources which we deem reliable. We do not represent that it is accurate or complete and it should not be relied upon as such. Research information taken from this report should be verified with the brokerage firm or analyst prior to being used in subsequent reports or news releases. * end of story *